The National Lung Cancer Screening Program (NLCSP) aims to achieve better health outcomes for Australians by detecting lung cancer early and reducing deaths from lung cancer. Early detection can lead to more effective treatment options and improved outcomes for patients.
The NLCSP is a screening program using low-dose computed tomography (LDCT) scans to look for lung cancer in high-risk people without any symptoms. It is targeted to eligible people aged between 50 to 70 years old with no signs or symptoms of lung cancer.
The program is an Australian Government initiative being implemented in partnership with the National Aboriginal Community Controlled Health Organisation (NACCHO) and Cancer Australia.
The program is being co-designed in partnership with communities and the healthcare workforce to be person-centred, equity-focused, accessible, and culturally safe. It is being co-designed to improve lung cancer outcomes for those disproportionately impacted by lung cancer including Aboriginal and Torres Strait Islander people and communities.
The program will commence from July 2025 and will help prevent over 500 deaths each year from lung cancer.
RANZCR invites all members to actively engage with the National Lung Cancer Screening Program (NLCSP) and get involved the opportunities it offers to enhance patient care.
The National Lung Cancer Screening Program will be presented at the RANZCR ASM.
Join the presentation - Friday 18 October 3:30 – 5:00 pm.
Hear more from Professor Dorothy Keefe, CEO Cancer Australia, Prof Catherine Jones, Dr Miranda Siemienowicz, Dr Annette McWilliams and Dr Sally Ayesa about the program and the progress to date.
RANZCR will be running webinars and workshops on the NLCSP in 2025. Stay tuned for dates!